Career & Filing History
Every role Jack W. Schuler has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
Jack W. Schuler is a beneficial owner of more than 10% of Aspira Women's Health Inc. (AWHL), as disclosed in SEC ownership filings. Schuler has also held reporting roles at BIODESIX INC (BDSX) and Accelerate Diagnostics, Inc (AXDX). Schuler has reported 12 insider filings with the SEC since 2024. The most recent filing was in June 2026.
Every role Jack W. Schuler has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
BIODESIX INC (BDSX)2 filingsAspira Women's Health Inc. (AWHL)1 filingUpdated Aug 31, 2026
Jack W. Schuler is 10% Owner of BIODESIX INC (BDSX). 14 SEC Form 4 filings on record going back to 2024, most recently on 13 August 2026. Most recent open-market trade: bought $367K of BDSX on 13 August 2026. Lifetime open-market purchases: $8.14M. Lifetime open-market sales: $314K. Historical track record: 3/5 stars across 13 tracked purchases.
Every recent SEC Form 4 transaction Jack W. Schuler has reported, most recent first.
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★★★☆☆ (3/5) |
| Total purchases tracked | 13 |
| Purchases with forward-return data | 13 |
| 30-day win rate | 54% |
| 90-day win rate | 46% |
| Avg 5-day return | +11.15% |
| Avg 30-day return | +7.67% |
| Avg 90-day return | +1.60% |
| Best 30-day return |
InsiderAlpha's records for Jack W. Schuler go back to 2024: 14 primary Form 4 filings, an average of 4.7 per year. The typical open-market purchase is $428K (19 buys totaling $8.14M). The largest single buy on record is $1.50M of BDSX in 2025. Sales side: 1 recorded sale totaling $314K, so the filing history runs buy-heavy by dollar value. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Insiders who reported open-market trades in the last 12 months at the companies Jack W. Schuler files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Jack W. Schuler is a corporate insider, tracked as 10% Owner of BIODESIX INC (BDSX). InsiderAlpha holds 14 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 19 open-market purchases ($8.14M) and 1 open-market sale ($314K) across all tracked filings.
Across 13 tracked purchases, Jack W. Schuler averaged +7.7% avg 30-day return with a 54% 30-day win rate. InsiderAlpha rates the track record at 3/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
$BDSX BIODESIX INC13.9K shares @ $24.25$337K
| +31.93% |